Search results
Results from the WOW.Com Content Network
Claim interpretation in patent, standard of review by the Federal Circuit. Commil USA, LLC v. Cisco Systems, Inc. 575 U.S. 632: 2015: 6-2 Defense to Indirect Infringement Standard of Induced Infringement A defendant's good-faith belief that a patent is invalid is not a defense to a claim of induced infringement. Case Law
Judge Pauline Newman of the Federal Circuit however criticized this ruling and argued that a good faith belief as to the invalidity of a patent was not a defense to induced infringement. Both parties subsequently appealed the Federal Circuit's opinion to the Supreme Court for further review. [3]
Blonder-Tongue Labs., Inc. v. University of Ill. Foundation, 402 U.S. 313 (1971), is a decision of the United States Supreme Court holding that a final judgment in an infringement suit against a first defendant that a patent is invalid bars the patentee from relitigating the same patent against other defendants. [1]
An invalidity opinion, also called "validity opinion", is a legal opinion provided by an attorney on how a court might rule on the validity of an issued patent. Invalidity opinions are often sought prior to patent litigation. See Patent infringement.
Patent claims are invalid as indefinite under 35 U.S.C. § 112 ¶ 2 when, in light of the specification and the prosecution history, they fail to inform, with reasonable certainty, those skilled in the art about the scope of the invention. Court membership; Chief Justice John Roberts Associate Justices Antonin Scalia · Anthony Kennedy
The European Patent Office declared a contested mRNA patent owned by Moderna invalid, the office said on Tuesday, handing a win to BioNTech and its partner Pfizer in a patent dispute between the ...
MedImmune was a licensee of the later Cabilly patent, but argued that the term had been improperly extended and that it need not continue to pay royalties past the original expiry date in March 2006. The case was decided in favor of MedImmune, and the United States Patent and Trademark Office (USPTO) declared the patent invalid. Genentech ...
Finally, we should not negate a key benefit of the U.S. patent system: It incentivizes Chinese firms to disclose their innovations publicly in English to seek an American patent, thereby spurring ...